“…We wondered whether intraocular hypertension correlated with the altered expression of dopamine and melatonin heteroreceptor complexes. First of all, we took advantage of an in vitro model of hypertension, described in Reference [54], consisting of the activation of the transient Interestingly, and as previously described by Alkozi et al, [34], none of the melatonin receptor agonists, melatonin or IIK7, were able to decrease cAMP levels in these cells. Next, we analyzed ERK1/2 phosphorylation, which was significantly enhanced when 7-OH-PIPAT was added ( Figure 4B,E).…”